TOP TIERMARKET NEWSWIRE
News & sentiment

JADE BIOSCIENCE INC (JBIO) — News & AI sentiment

JADE BIOSCIENCE INC (JBIO) news roundup. 2 stories in the past week, 4 over 30 days. Average 30-day sentiment is 54.5/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
2
avg sentiment 52/100
30d stories
4
avg sentiment 54.5/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

JBIO news in the last 24 hours, 7 days, 30 days and 90 days

How much JBIO coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowJBIO storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days252/100JBIO headlines →
Last 30 days454.5/100JBIO headlines →
Last 90 days1657.6/100JBIO headlines →

Latest stories on JBIO

Jade Biosciences to Participate in Upcoming Conferences
Business Insider52 · neutralproduct/pr
6d ago
6d ago
Oct 21
Oct 19
H.C. Wainwright reiterates Jade Biosciences stock rating at buy
Investing.com Analyst Ratings61 · neutralanalyst
Oct 1
Wedbush reiterates Jade Biosciences stock rating on preclinical data
Investing.com Analyst Ratings56 · neutralanalyst
Oct 1
Sep 30
Stifel reiterates Jade Biosciences stock rating on drug data
Investing.com Analyst Ratings56 · neutralanalyst
Sep 30
Sep 30
Jade Biosciences, Inc. (JBIO) files 8-K
SEC 8-K50 · neutralgeneral
Sep 30
Sep 9
Sep 3
Sep 1
Jade Biosciences: Duration Is The Real Product
Seeking Alpha63 · neutralproduct/pr
Aug 19
Aug 11
Aug 11
Jade Biosciences, Inc. GAAP EPS of -$0.76
Seeking Alpha34 · bearishearnings
Aug 10
Wedbush raises Jade Biosciences price target on pipeline progress
Investing.com Analyst Ratings61 · neutralanalyst
Aug 10
Jade Biosciences, Inc. (JBIO) files 8-K
SEC 8-K50 · neutralgeneral
Aug 10
Aug 10
Aug 10
Jade Biosciences, Inc. (JBIO) files 8-K
SEC 8-K50 · neutralgeneral
Jul 1
Jun 30
Jun 26
Jade Biosciences, Inc. (JBIO) files 8-K
SEC 8-K50 · neutralgeneral
Jun 26
Open JBIO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →